Literature DB >> 33573621

Left ventricular ejection fraction and right atrial diameter are associated with deep regional CBF in arteriosclerotic cerebral small vessel disease.

Xiaodong Chen1, Danli Lu1, Ning Guo2, Zhuang Kang2, Ke Zhang2, Jihui Wang3, Xuejiao Men1, Zhengqi Lu1, Wei Qiu4.   

Abstract

BACKGROUND: Systemic cardiac hypoperfusion is a well-acknowledged contributor to ischemic leukoencephalopathy. However, it has remained elusive how atherosclerosis-mediated cardiac remodelling modifies cerebral perfusion homeostasis as well as neuroimaging burden in cerebral small vessel disease (CSVD) development.
METHODS: This retrospective study identified 103 arteriosclerotic CSVD (aCSVD) patients (CSVD burdenlow 0 ~ 1, n = 61 and CSVD burdenhigh 2 ~ 4, n = 42) from Sep. 2017 to Dec. 2019 who underwent transthoracic echocardiography(n = 81), structural magnetic resonance imaging and arterial spin labelling (ASL). Total CSVD burden was graded according to the ordinal "small vessel disease" rating score (0-4). We investigated the univariate and multivariate linear regression of mean deep regional cerebral blood flow (CBF) as well as logistic regression analysis of CSVD burdenhigh.
RESULTS: Right atrial diameter (B coefficient, - 0.289; 95% CI, - 0.578 to - 0.001; P = 0.049) and left ventricular ejection fraction (B coefficient, 32.555; 95% CI, 7.399 to 57.711; P = 0.012) were independently associated with deep regional CBF in aCSVD patients. Binary logistic regression analysis demonstrated decreased deep regional CBF (OR 0.894; 95% CI 0.811-0.985; P = 0.024) was independently associated with higher CSVD burden after adjusted for clinical confounders. Multivariate receiver operating characteristics curve integrating clinical risk factors, mean deep CBF and echocardiographic parameters showed predictive significance for CSVD burdenhigh diagnosis (area under curve = 84.25, 95% CI 74.86-93.65%, P < 0.0001).
CONCLUSION: The interrelationship of "cardiac -deep regional CBF-neuroimaging burden" reinforces the importance and prognostic significance of echocardiographic and cerebral hemodynamic assessment in CSVD early-warning.

Entities:  

Keywords:  Arteriolosclerosis; CSVD burden; Cerebral blood flow; Cerebral small vessel disease; Echocardiography

Mesh:

Year:  2021        PMID: 33573621      PMCID: PMC7877009          DOI: 10.1186/s12883-021-02096-w

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  33 in total

1.  Atlas-derived perfusion correlates of white matter hyperintensities in patients with reduced cardiac output.

Authors:  Angela L Jefferson; Christopher M Holland; David F Tate; Istvan Csapo; Athena Poppas; Ronald A Cohen; Charles R G Guttmann
Journal:  Neurobiol Aging       Date:  2009-03-09       Impact factor: 4.673

2.  Left ventricular ejection fraction is associated with small vessel disease in ischaemic stroke patients.

Authors:  K-W Nam; H-M Kwon; H-L Kim; Y-S Lee
Journal:  Eur J Neurol       Date:  2019-02-03       Impact factor: 6.089

3.  The measurement of affects: depression and anxiety.

Authors:  W W Zung
Journal:  Mod Probl Pharmacopsychiatry       Date:  1974

4.  Quantitative and qualitative MRI evaluation of cerebral small vessel disease in an elderly population: a longitudinal study.

Authors:  Ruta Nylander; Markus Fahlström; Egill Rostrup; Joel Kullberg; Soheil Damangir; Håkan Ahlström; Lars Lind; Elna-Marie Larsson
Journal:  Acta Radiol       Date:  2017-08-16       Impact factor: 1.990

Review 5.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

Review 6.  The glymphatic pathway in neurological disorders.

Authors:  Martin Kaag Rasmussen; Humberto Mestre; Maiken Nedergaard
Journal:  Lancet Neurol       Date:  2018-11       Impact factor: 44.182

7.  Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease.

Authors:  Fergus N Doubal; Alasdair M J MacLullich; Karen J Ferguson; Martin S Dennis; Joanna M Wardlaw
Journal:  Stroke       Date:  2010-01-07       Impact factor: 7.914

Review 8.  Cerebral blood flow in small vessel disease: A systematic review and meta-analysis.

Authors:  Yulu Shi; Michael J Thrippleton; Stephen D Makin; Ian Marshall; Mirjam I Geerlings; Anton J M de Craen; Mark A van Buchem; Joanna M Wardlaw
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-05       Impact factor: 6.200

9.  Cerebral hemodynamics in normal aging: central artery stiffness, wave reflection, and pressure pulsatility.

Authors:  Takashi Tarumi; Muhammad Ayaz Khan; Jie Liu; Benjamin Y Tseng; Benjamin M Tseng; Rosemary Parker; Jonathan Riley; Cynthia Tinajero; Rong Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-19       Impact factor: 6.200

10.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.